NYSE · Health Care · Diagnostics & Research
TMO
Thermo Fisher Scientific Inc.
Sells lab instruments and reagents, and runs contract research and drug-manufacturing services for pharma customers.
$588.29-1.28%
Close · 2026-08-14$450$500$550$600
NovFebMayAug
$434.83
$642.7152-week range, last close at 74% of the range
- 1W
- -0.96%
- 1M
- +9.90%
- 3M
- +34.34%
- 6M
- +16.77%
- YTD
- +1.73%
- 1Y
- +21.73%
- Avg vol 20d
- 2.2M
- RVOL
- 0.47
- HOLD band
Fundamentalsas of 2026-08-14
- Mkt cap
- $217.52B
- P/E
- 31.6
- Fwd P/E
- 21.4
- EPS
- $18.59
- Div yield
- 0.32%
- Beta
- 0.85
- Employees
- 125K
- Next earnings
- 2026-10-21
Rating & verdict historyoldest → newest
100.0% correct+0.96% avg moveBUY 1/1 · HOLD 0/0 · SELL 0/0
| Date | Call | Outcome | Return | Takeaway |
|---|---|---|---|---|
| 2026-08-14 | Subscribers | — | — | Subscribe to read |
| 2026-08-13 | Subscribers | — | — | Subscribe to read |
| 2026-08-12 | Subscribers | — | — | Subscribe to read |
| 2026-08-11 | Subscribers | — | — | Subscribe to read |
| 2026-08-10 | Subscribers |